EntryPoint Capital’s Ventyx Biosciences VTYX Stock Holding History

EntryPoint Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,708	Closed	-$160K	–	935
2025 Q4	$160K	Buy	+17,708	New	+$132K	0.06%	583

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EntryPoint Capital's VTYX Position: Q1 2026 in Review

EntryPoint Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 17,708 shares — an estimated $160K sold.

EntryPoint Capital first reported a position in VTYX in Q4 2025 and held it in 1 quarter. The position peaked at $160K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

EntryPoint Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
EntryPoint Capital sold 17,708 Ventyx Biosciences shares in Q1 2026, an estimated $160K.
EntryPoint Capital first reported a position in Ventyx Biosciences in Q4 2025 and held it in 1 quarter.
EntryPoint Capital's Ventyx Biosciences position peaked at $160K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.